Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Medication errors in people with cognitive decline create a dangerous cycle: the very changes in thinking, memory, and judgment that define dementia make it harder to take medications safely, and those medication mistakes can further worsen cognitive symptoms. Patients who struggle to keep up with their medications—missing four or more adherence measures—face a doubled risk of developing dementia and a 148% increased risk of Alzheimer’s disease. This isn’t simply a matter of forgetfulness. When someone with early cognitive decline forgets a dose, takes medication twice, or mixes up which pills to take, they may be setting themselves up for serious adverse events that accelerate their decline further. Consider a 72-year-old woman with mild memory loss who is prescribed a benzodiazepine for anxiety and an anticholinergic antidepressant for mood. The cognitive side effects of these medications—confusion, disorientation, further memory loss—can feel identical to progressing dementia, making it nearly impossible for her or her family to tell if her decline is disease progression or a reversible medication effect.
The relationship between cognitive impairment and medication errors is bidirectional and urgent. As cognition declines, the risk of medication errors rises dramatically. At the same time, many of the drugs prescribed to older adults with cognitive concerns actually impair cognition further. Healthcare systems are not structured to catch this pattern early. Fewer than 15% of people with mild cognitive impairment are recognized by their healthcare providers, leaving the vast majority at risk without knowing it. The financial toll is staggering—medication-related adverse events cost the healthcare system $38 to $50 billion annually in extra costs, disability, and lost productivity. For families managing dementia care, understanding how cognitive decline and medication safety interact is essential to preventing harm.
Table of Contents
- What Cognitive Changes Make Medication Errors More Likely?
- Which Medications Pose the Greatest Cognitive Risks?
- Polypharmacy and the Cascade of Inappropriate Medications
- How Multiple Prescribers Create Medication Error Risk
- Why Healthcare Providers Miss Cognitive Impairment Until It’s Too Late
- The Cost and Clinical Consequences of Medication Errors in Cognitive Decline
- Recent Research and Moving Forward
- Conclusion
What Cognitive Changes Make Medication Errors More Likely?
Cognitive decline affects every step of medication management. Memory loss means patients forget whether they took their pills today or yesterday. Confusion about time makes it hard to follow a twice-daily or three-times-daily schedule. Executive function problems—the ability to plan and organize—make it difficult to refill prescriptions before running out or to coordinate multiple medications. Reduced judgment means someone might decide to take extra doses because they “feel worse,” or skip doses because they feel better and assume they don’t need the medication anymore. A 68-year-old man with early dementia might stop taking his blood pressure medication entirely because he feels fine, not realizing that the medication is what’s keeping his blood pressure controlled.
His wife discovers this only when he has a stroke weeks later. The specifics matter because they tell us where errors are most likely to happen. Research on medication dispensing errors shows that cognitive changes in older adults significantly increase the risk of forgotten doses, accidental duplication (taking the same medication twice), and misunderstanding medication instructions. Someone with mild cognitive impairment might read the label “take one tablet twice daily” and genuinely not remember what they did yesterday, so they take it whenever they think of it—sometimes three times in a day, sometimes only once. For people living alone, there’s no one to catch these errors. For people in shared housing with family or caregivers, the errors might not be noticed until a medication interaction or overdose causes an emergency.
Which Medications Pose the Greatest Cognitive Risks?
Not all medications affect cognition equally. Research from a large real-world pharmacovigilance study found that analgesics (pain relievers) are the leading medication class associated with drug-induced cognitive impairment, followed by sedative-hypnotics (sleep aids and anti-anxiety medications). This is especially concerning because pain and sleep problems are extremely common in older adults, and these medications are often prescribed without adequate discussion of cognitive risks. Anticancer drugs and anti-Parkinson medications are more likely to cause *serious* cognitive impairment, but they’re prescribed in more limited circumstances. The biggest concern for most families managing cognitive decline is that benzodiazepines (including lorazepam, diazepam, and alprazolam), anticholinergic antidepressants, and antipsychotics—all commonly prescribed for anxiety, mood, and behavior problems in dementia—are explicitly linked to cognitive decline in older adults with long-term use.
Why are benzodiazepines particularly problematic? They work by slowing down brain activity, which can temporarily reduce anxiety but at the cost of impaired memory formation, reduced attention, and confusion—the exact opposite of what someone with dementia needs. A 76-year-old woman prescribed lorazepam for anxiety related to her memory loss finds that the medication makes her memory worse, creating more anxiety, leading the doctor to increase the dose. She becomes caught in a spiral where medication side effects and disease symptoms are indistinguishable. The limitation here is critical: deprescribing these medications is often difficult because stopping them suddenly can cause withdrawal and rebound anxiety, so patients and families may feel trapped between the side effects of the medication and the risks of stopping it. Switching to alternatives like selective serotonin reuptake inhibitors (SSRIs) or behavioral interventions takes time and requires a provider willing to make these changes.
Polypharmacy and the Cascade of Inappropriate Medications
Polypharmacy—taking five or more medications—is nearly universal among older adults with cognitive concerns, and it is a major risk factor for medication errors and adverse events. The problem multiplies with each additional medication. Someone taking multiple medications has more opportunities to make mistakes, more chances for drug-drug interactions, and more of a cognitive burden to keep track of everything. Even more concerning: studies show that 14% to 74% of people with dementia take potentially inappropriate medications—drugs that are either known to be risky in older adults with cognitive impairment or are simply not needed. These patients experience increased adverse events, greater healthcare utilization, and higher mortality.
Over half of older adults with dementia who also have kidney disease have inappropriate drug dosing, meaning they’re taking standard doses of medications their bodies can’t clear properly, leading to dangerous accumulation. When kidney function declines with age or disease, medications that are normally safe become toxic. A 74-year-old man with dementia and mild kidney disease is prescribed a standard dose of a sedative pain reliever that his body can’t eliminate efficiently. Over weeks, it builds up in his system, causing increased confusion, falls, and hospitalizations—complications that look like advancing dementia but are actually drug toxicity. The tragedy is that this is entirely preventable if someone is monitoring kidney function and adjusting doses accordingly. Yet in fragmented healthcare systems, the primary care doctor may not know that the hospital prescribed a new medication, or the specialist may not know about the kidney disease.
How Multiple Prescribers Create Medication Error Risk
One of the most overlooked risk factors is having multiple prescribers with poor communication between them. A patient seeing a cardiologist, a psychiatrist, a neurologist, and a primary care doctor might receive four different medications that interact dangerously—and no single provider knows about all four. Risk factors for medication errors include multiple medications, the presence of multiple chronic conditions (comorbidities), being female, and crucially, having multiple prescribers without adequate coordination. The research identifies gender as a risk factor: women are at higher risk for medication errors, which likely reflects a combination of sex differences in drug metabolism, hormone changes with age, and potential differences in how providers discuss medications with different genders.
The warning here is stark: fragmentation in healthcare delivery is a medication safety hazard. A 70-year-old woman with dementia sees five different specialists and her primary care doctor. The cardiologist prescribes a beta-blocker, the neurologist prescribes a Parkinson’s medication, the psychiatrist prescribes an antidepressant and an antipsychotic for behavior problems, the pain specialist prescribes an opioid, and the primary care doctor prescribes a sleeping aid. Nobody has sat down to look at the whole picture. Nobody has asked: do all six of these medications make sense together? Are we treating side effects of other medications? Is there overlap? Preventing this requires deliberate action: family members often need to serve as medication coordinators, maintaining a complete list and bringing it to every appointment, or someone needs to recommend a medication review by a pharmacist or geriatrician who can see the complete picture.
Why Healthcare Providers Miss Cognitive Impairment Until It’s Too Late
Here lies a critical failure point: healthcare providers recognize mild cognitive impairment in fewer than 15% of cases. This means that the vast majority of people with early cognitive decline are not identified and not flagged as being at high risk for medication errors. Without a diagnosis of MCI or dementia, the standard instructions for taking medications—”take as directed”—make no accommodation for cognitive limitations. A patient with unrecognized mild cognitive impairment looks cognitively normal in a brief office visit, especially if they’re articulate and have ways of hiding their memory problems. But at home, they’re forgetting doses, struggling to follow written instructions, and making medication errors that nobody recognizes as part of a larger cognitive pattern.
The limitation in current practice is that cognitive screening is not routine, especially in primary care where most medication prescribing happens. A quick mental status test takes five minutes but is rarely done. So patients drift along, accumulating medications for conditions that might actually be related to unrecognized cognitive decline or medication side effects, until something catastrophic happens. A recent study from January 2026 found that millions of people with dementia are still prescribed medications strongly linked to falls and confusion—suggesting that even with a dementia diagnosis, providers aren’t adequately adjusting medication regimens to account for cognitive status. This is both a systems problem (nobody has time to do comprehensive medication reviews) and a knowledge problem (many providers aren’t aware that certain medications are especially risky in dementia).
The Cost and Clinical Consequences of Medication Errors in Cognitive Decline
The financial impact of medication-related adverse events—$38 to $50 billion annually—translates to real consequences for patients and families. Hospitalizations, emergency department visits, extended hospital stays, rehabilitation costs, and lost productivity all add up. But beyond the dollars is the human cost: medication errors in someone with dementia can trigger a cascade of complications. A forgotten dose of a Parkinson’s medication causes rigidity and immobility, leading to a fall. The fall requires hospitalization. During the hospital stay, the patient develops an infection and becomes delirious.
The delirium makes the dementia appear worse. By the time the patient goes home, their functional status has declined permanently. What started as a medication adherence error has accelerated cognitive and physical decline in a way that may be irreversible. Males and people with cancer diagnoses are identified in recent research as having higher rates of hospitalization due to serious drug-induced cognitive impairment. This suggests that certain patient populations face compounded risk—possibly because cancer medications themselves are cognitively toxic, or because patients with cancer see more specialists and take more medications, or because there’s less attention paid to cognitive side effects when someone is already managing a life-threatening disease. For families, this underscores that nobody is immune to medication-related cognitive harm, and that vigilance is required especially in complex medical situations.
Recent Research and Moving Forward
A study released in January 2026 by researchers examining medication prescribing patterns in dementia found that millions of people with dementia are still taking drugs that significantly increase the risk of falls, confusion, and further cognitive decline. This finding is simultaneously reassuring and alarming: reassuring because it means the problem is now being documented and studied; alarming because it shows how slowly clinical practice changes even when evidence is clear.
The medications in question—anticholinergics, benzodiazepines, and certain pain relievers—have been known to be risky in older adults and especially in dementia for years, yet they remain commonly prescribed. The future of medication safety in dementia likely involves three changes: first, routine cognitive screening in primary care so that cognitive impairment is detected early; second, comprehensive medication reviews that explicitly consider cognitive risks and drug interactions; and third, better coordination between providers, perhaps through shared electronic health records that show all medications and flag dangerous combinations. Until those systemic changes take hold, families and patients need to be their own safeguards—maintaining updated medication lists, asking prescribers specifically about cognitive side effects, questioning whether each medication is still necessary, and arranging regular pharmacist reviews when possible.
Conclusion
Medication errors in cognitive decline are not inevitable. They are the result of a predictable sequence: cognitive changes make it harder to manage medications correctly, many commonly prescribed medications further impair cognition, healthcare systems fail to detect mild cognitive impairment early, and multiple prescribers don’t communicate with each other. Breaking this cycle requires awareness, coordination, and sometimes hard conversations with providers about whether a medication is truly necessary or whether its cognitive risks outweigh its benefits. For families caring for someone with dementia or early cognitive decline, the most important step is to recognize that medication management is part of dementia care itself—it requires the same attention and support that other aspects of care do.
If you suspect that a loved one’s cognitive decline is being made worse by medications, or if you notice new confusion or memory problems after starting a new drug, ask their healthcare provider directly: Is this a medication side effect or disease progression? Request a comprehensive medication review. Ask whether each medication is still necessary. Bring a complete medication list to every appointment, and ask the pharmacist to check for interactions. These steps can prevent the tragic situation where a reversible medication problem is mistaken for advancing disease, and where medication errors accelerate cognitive decline that might have been slowed or managed better with appropriate adjustments.
